4-Hydroxybutanoic Acid: Side Effects, Uses & Monitoring
Facts extracted from current FDA product labeling for 4-Hydroxybutanoic Acid. Educational only — not medical advice.
Labeled uses
Sodium oxybate oral solution is indicated for the treatment of cataplexy or excessive daytime sleepiness (EDS) in patients with narcolepsy. Pediatric use information is approved for Jazz Pharmaceuticals Inc.’s XYREM (sodium oxybate) Oral Solution. However, due to Jazz Pharmaceuticals Inc.’s marketing exclusivity rights, this drug product is not labeled with that pediatric information.
Source: FDA labeling via NIH DailyMed (set 5a9e9045…). Not affiliated with FDA or NIH.
Medical disclaimer: Always consult a qualified healthcare professional about any medication.